LyP-1-conjugated Fe₃O₄ nanoparticles suppress tumor growth by magnetic induction hyperthermia

References

• Stewart B, Wild CP. World cancer report 2014. Geneva: World Health Organization; 2014.
   Google Scholar
• Institute NC. Cancer stat facts: female breast cancer; [cited 2017 Aug 13]. Available from: https://seer.cancer.gov/statfacts/html/breast.html
   Google Scholar
• Thu Huong LT, Nam NH, Doan DH, et al. Folate attached, curcumin loaded Fe3O4 nanoparticles: a novel multifunctional drug delivery system for cancer treatment. Mater Chem Phys. 2016;172:98–104.10.1016/j.matchemphys.2015.12.065
   Web of Science ®Google Scholar
• Oh Y, Lee N, Kang HW, et al. In vitro study on apoptotic cell death by effective magnetic hyperthermia with chitosan-coated MnFe2O4. Nanotechnology 2016;27(11):115101.10.1088/0957-4484/27/11/115101
   PubMed Web of Science ®Google Scholar
• Veiseh O, Gunn JW, Zhang M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev. 2010;62(3):284–304.10.1016/j.addr.2009.11.002
   PubMed Web of Science ®Google Scholar
• Hsieh HC, Kuan IC, Lee SL, et al. Stabilization of d-amino acid oxidase from Rhodosporidium toruloides by immobilization onto magnetic nanoparticles. Biotech Lett. 2009;31(4):557–563.10.1007/s10529-008-9894-z
   PubMed Web of Science ®Google Scholar
• Van dZJ. Heating the patient: a promising approach? Ann Oncol. 2002;13(8):1173.
   PubMed Web of Science ®Google Scholar
• Dudar TE, Jain RK. Differential response of normal and tumor microcirculation to hyperthermia. Cancer Res. 1984;44(2):605–612.
   PubMed Web of Science ®Google Scholar
• Kruse AM, Meenach SA, Anderson KW, et al. Synthesis and characterization of CREKA-conjugated iron oxide nanoparticles for hyperthermia applications. Acta Biomater. 2014 Jun;10(6):2622–2629.10.1016/j.actbio.2014.01.025
   PubMed Web of Science ®Google Scholar
• Johannsen M, Thiesen B, Wust P, et al. Magnetic nanoparticle hyperthermia for prostate cancer. Int J Hyperth. 2010;26(8):790–795.10.3109/02656731003745740
   PubMed Web of Science ®Google Scholar
• Thiesen B, Jordan A. Clinical applications of magnetic nanoparticles for hyperthermia. Int J Hyperth. 2008 Sep;24(6):467–474.10.1080/02656730802104757
   PubMed Web of Science ®Google Scholar
• Paasonen L, Sharma S, Braun GB, et al. New p32/gC1qR ligands for targeted tumor drug delivery. ChemBioChem. 2016;17(7):570–575.10.1002/cbic.v17.7
   PubMed Web of Science ®Google Scholar
• Ruoslahti E, Bhatia SN, Sailor MJ. Targeting of drugs and nanoparticles to tumors. J Cell Biol. 2010;188(6):759–768.10.1083/jcb.200910104
   PubMed Web of Science ®Google Scholar
• Yan Z, Wang F, Wen Z, et al. LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor. J Control Release. 2012;157(1):118–125.10.1016/j.jconrel.2011.07.034
   PubMed Web of Science ®Google Scholar
• Yan Z, Zhan C, Wen Z, et al. LyP-1-conjugated doxorubicin-loaded liposomes suppress lymphatic metastasis by inhibiting lymph node metastases and destroying tumor lymphatics. Nanotechnology 2011;22(41):415103.10.1088/0957-4484/22/41/415103
   PubMed Web of Science ®Google Scholar
• Park JH, von Maltzahn G, Xu MJ, et al. Cooperative nanomaterial system to sensitize, target, and treat tumors. Proc Nat Acad Sci. 2010;107(3):981–986.10.1073/pnas.0909565107
   PubMed Web of Science ®Google Scholar
• Luo G, Yu X, Jin C, et al. LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors. Int J Pharm. 2010;385(1–2):150–156.10.1016/j.ijpharm.2009.10.014
   PubMed Web of Science ®Google Scholar
• Karmali PP, Kotamraju VR, Kastantin M, et al. Targeting of albumin-embedded paclitaxel nanoparticles to tumors. Nanomed Nanotechnol Biol Med. 2009;5(1):73–82.10.1016/j.nano.2008.07.007
   PubMed Web of Science ®Google Scholar
• Wang X, Kan S, Zhao L, et al., editors. Surface-modification superparamagnetic nanoparticles for highly-efficient intracellular hyperthermia. Chengdu: International Conference on Bioinformatics and Biomedical Engineering; 2010.
   Google Scholar
• Wang X, Zhang J, Yang X, et al. In vivo assessment of hepatotoxicity, nephrotoxicity and biodistribution using 3-aminopropyltriethoxysilane-coated magnetic nanoparticles (APTS-MNPs) in ICR mice. Chin Sci Bull. 2014;59(16):1800–1808.10.1007/s11434-014-0296-4
   Google Scholar
• Gao F, Cai Y, Zhou J, et al. Pullulan acetate coated magnetite nanoparticles for hyper-thermia: Preparation, characterization and in vitro experiments. Nano Res. 2010;3(1):23–31.10.1007/s12274-010-1004-6
   Web of Science ®Google Scholar
• Chen B, Wang X, Kan S, et al. Protamine-modified iron oxide magnetic nanoparticles are efficient gene vectors for magnetofection. Sci Technol Rev. 2010;28(19):62.
   Google Scholar
• Liu J, Li N, Li L, et al. Local hyperthermia for esophageal cancer in a rabbit tumor model: magnetic stent hyperthermia versus magnetic fluid hyperthermia. Oncol Lett. 2013;6(6):1550–1558.
   PubMed Web of Science ®Google Scholar
• Leon-Blanco MM, Guerrero JM, Reiter RJ, et al. Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro. J Pineal Res. 2003 Oct;35(3):204–211.10.1034/j.1600-079X.2003.00077.x
   PubMed Web of Science ®Google Scholar
• Zhao FY, Li YL, Li LH. Preparation and characterization of magnetite nanoparticles. Appl Mech Mater. 2014;618(618):24–27.10.4028/www.scientific.net/AMM.618
   Google Scholar
• Waldron RD. Infrared spectra of ferrites. Phys Rev. 1955;99(6):1727–1735.10.1103/PhysRev.99.1727
   Web of Science ®Google Scholar
• Park JY, Daksha P, Lee GH, et al. Highly water-dispersible PEG surface modified ultra small superparamagnetic iron oxide nanoparticles useful for target-specific biomedical applications. Nanotechnology 2008;19(36):365603.10.1088/0957-4484/19/36/365603
   PubMed Web of Science ®Google Scholar
• Saha A, Mohapatra S, Kurkute P, et al. Targeted delivery of a novel peptide–docetaxel conjugate to MCF-7 cells through neuropilin-1 receptor: reduced toxicity and enhanced efficacy of docetaxel. RSC Adv. 2015;5(112):92596–92601.10.1039/C5RA16741H
   Web of Science ®Google Scholar